View Post The Impact of Socioeconomic Status on HPV Infection Among Young Brazilians in a Nationwide Multicenter Study. Preventive Medicine Reports, 21: 1-7. In by AHFJanuary 15, 2021
View Post Incident Type 2 Diabetes Mellitus after Initiation of Common HIV Antiretroviral Drugs. AIDS, 35: 81-90. In by AHFJanuary 15, 2021
View Post Community Pharmacists: On the Frontline of Health Service Against COVID- 19 in LMICs. Research in Social and Administrative Pharmacy, 17: 1964-1966. In by AHFJanuary 15, 2021
View Post Brazilian Protocol for Sexually Transmitted Infections 2020: Acquired Syphilis. Journal of the Brazilian Society of Tropical Medicine, 54: 1-8. In by AHFJanuary 15, 2021
View Post Prevalence of human immunodeficiency virus-1 drugresistant mutations among adults on first- and second-line antiretroviral therapy in a resourcelimited health facility in Busia County, Kenya. The Pan African Medical Journal, 37(311): 1-11. In by AHFDecember 15, 2020
View Post Discrepancies Between Self-Reported Adherence and a Biomarker of Adherence in Real-World Settings. Journal of Acquired Immune Deficiency Syndrome, 85(4): 454-457. In by AHFDecember 1, 2020
View Post Antiretroviral Therapy and Liver Disorders in the OPERA® Cohort. Therapeutic Advances in Drug Safety, 11: 1-12. In by AHFNovember 15, 2020
View Post Risk of Chronic Kidney Disease in People Living with HIV by Tenofovir Disoproxil Fumarate (TDF) Use and Baseline D:A:D Chronic Kidney Disease Risk Score. HIV Medicine, 22(5): 325-333. In by AHFNovember 1, 2020
View Post Assessing Bias Introduced in Estimated Glomerular Filtration Rate by the Inhibition of Creatinine Tubular Secretion from Common Antiretrovirals. Antiviral Therapy, 25(5): 287-292. In by AHFOctober 15, 2020
View Post Hepatitis B Infection in People Living with HIV Who Initiate Antiretroviral Therapy in Zimbabwe. Public Health Action, 10(3): 97-103. In by AHFSeptember 15, 2020
